Status:
COMPLETED
Topical Ice-therapy for Intravitreal Injections
Lead Sponsor:
University of Minnesota
Conditions:
Anesthesia; Hypothermia
Injection Site Irritation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose: To examine the difference in patient's pain experience in the setting of intravitreal anti-VEGF injections with pretreatment of topical ice-therapy compared with no-ice.
Eligibility Criteria
Inclusion
- All patients aged 18 or older evaluated by a single retina specialist at the University of Minnesota Department of Ophthalmology with a clinical indication necessitating an anti-VEGF intravitreal injection
Exclusion
- N/A
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05269823
Start Date
April 1 2022
End Date
April 30 2025
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455